Nova Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.3K Sell
67
-5
-7% -$1.71K 0.01% 304
2026
Q1
$25.3K Buy
72
+3
+4% +$1.07K 0.02% 274
2025
Q4
$22.6K Sell
69
-15
-18% -$4.76K 0.02% 277
2025
Q3
$23.7K Sell
84
-26
-24% -$7.54K 0.02% 283
2025
Q2
$30.7K Sell
110
-13
-11% -$3.68K 0.02% 266
2025
Q1
$38.3K Buy
123
+122
+12,200% +$36K 0.03% 224
2024
Q4
$261 Buy
+1
New +$297 ﹤0.01% 367

Other funds holding AMGN

Nova Wealth Management's AMGN Position: Q2 2026 in Review

Nova Wealth Management reduced its Amgen (AMGN) stake by 6.9% in Q2 2026, selling an estimated $1.71K and leaving 67 shares worth $24.3K. The position accounts for 0.01% of the portfolio, ranked #304.

Nova Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $38.3K in Q1 2025. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nova Wealth Management held 67 shares of Amgen worth $24.3K as of Q2 2026.
  • Nova Wealth Management sold 5 Amgen shares in Q2 2026, an estimated $1.71K.
  • Amgen made up 0.01% of Nova Wealth Management's portfolio in Q2 2026, its #304 holding.
  • Nova Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Nova Wealth Management's Amgen position peaked at $38.3K in Q1 2025.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nova Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.